- Home
- RSSS vs IKNA Comparison
RSSS vs IKNA Comparison
Compare RSSS & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- IKNA
- Stock Information
- Founded
- RSSS 2006
- IKNA 2016
- Country
- RSSS United States
- IKNA United States
- Employees
- RSSS N/A
- IKNA N/A
- Industry
- RSSS Business Services
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- IKNA Health Care
- Exchange
- RSSS Nasdaq
- IKNA Nasdaq
- Market Cap
- RSSS 90.6M
- IKNA 61.8M
- IPO Year
- RSSS N/A
- IKNA 2021
- Fundamental
- Price
- RSSS $3.04
- IKNA $1.32
- Analyst Decision
- RSSS
- IKNA Strong Buy
- Analyst Count
- RSSS 0
- IKNA 1
- Target Price
- RSSS N/A
- IKNA $4.00
- AVG Volume (30 Days)
- RSSS 48.7K
- IKNA 59.9K
- Earning Date
- RSSS 05-08-2025
- IKNA 08-07-2025
- Dividend Yield
- RSSS N/A
- IKNA N/A
- EPS Growth
- RSSS N/A
- IKNA N/A
- EPS
- RSSS N/A
- IKNA N/A
- Revenue
- RSSS $48,753,578.00
- IKNA N/A
- Revenue This Year
- RSSS $12.42
- IKNA N/A
- Revenue Next Year
- RSSS $7.47
- IKNA N/A
- P/E Ratio
- RSSS N/A
- IKNA N/A
- Revenue Growth
- RSSS 14.85
- IKNA N/A
- 52 Week Low
- RSSS $2.32
- IKNA $0.97
- 52 Week High
- RSSS $4.24
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- RSSS 63.45
- IKNA 51.66
- Support Level
- RSSS $2.73
- IKNA $1.31
- Resistance Level
- RSSS $2.90
- IKNA $1.36
- Average True Range (ATR)
- RSSS 0.11
- IKNA 0.04
- MACD
- RSSS 0.02
- IKNA -0.01
- Stochastic Oscillator
- RSSS 88.00
- IKNA 13.61
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.